Parathyroid lipohyperplasiaisan extremely rare causeof hyperparathyroidism. According to a MEDLINE search, there havebeen only9 previously reported cases ofparathyroid lipohyperplasia intheEnglish-language literature. Wereport a newcaseofparathyroid lipohyperplasia, with a brief discussion of this rare disease process.
Introduction
Parathyroid hyperplasia is a cause of hyperparathyroidism defined as a proliferation of parenchymal cells leading to an increase in gland weight.' This increase in weight is a result (at least in part) of the glands' high adipose tissue content. The two most common types of parathyroid hyperplasia are chief cell hyperplasia and water-clearcell hyperplasia. Only 9 casesof parathyroid lipohyperplasia previously have been reported in the English literature. 2 -4 Case report A 60-year-old woman was referred to our clinic with a l-year history of recurrent kidney stones; one episode had beencomplicatedbyurosepsis. Shehad experienced multiple urinary tract infections during this time. Her medicalhistorywassignificantfora3-yearhistory ofhypothyroidism treated with levothyroxine(L-thyroxine), and her current thyroid-stimulating hormone levelwas 6.24 mIU/L (normal 0.30 to 3.0).
Preoperativelaboratory studies revealeda parathyroid hormone (PTH) level of26.8 pg/ml (normal 15 to 65) with a serum calcium level of 11.3 mg/dl (normal 8.9 to 10.1). The patient's PTH had been as high as 65 pg/ml with a calcium level at that time of 9.4 mg/dl. Twentyfour-hour urine calciumwasnormal at 210mg/24hours. Computed tomography of the abdomen revealed persistent bilateralnephrolithiasis,and a bone density scan showed well-preservedbone mass. Sestamibiscanning wassignificantfora subtle mismatch ofthe dual isotope images corresponding to the inferior right pole of the thyroid. Further imaging by ultrasonography showed two discrete nodules in the left thyroid-c-one measuring 6 mm and the other, which wascystic,measuring 4 mm. There was no evidence of parathyroid adenoma.
Thepatientunderwent four-glandparathyroidexploration with resectionofthreeand a halfparathyroidglands. After resection, the patient's intraoperative PTH levels fell from a baseline of 144pg/ml to 15 pg/ml at 5 minutes, and to 13.9 pg/ml by 15 minutes. Postoperatively, the patient'scalcium level ranged from 7.6to 8.7 mg/dl.
The resected specimens consisted of tissue from all fourparathyroidglands;allwereenlarged. In comparison to a normal parathyroid gland (figure, A), the glands showedan admixture of predominantly mature adipose tissue in addition to normal parathyroid stroma (figure, B).Theglands' weightand composition wereas follows:
• The left inferior parathyroid weighed 235 mg; 70% adipose (normal 40 to 65 mg and up to 30%adipose).
• The right inferior gland was 209 mg; 70%adipose.
• Theleftsuperior gland weighed80 mg;40%adipose.
• Half of the right superior gland weighed 64 mg; 70% adipose.
Four days postoperatively, the patient's calcium levels normalized to 9.3 to 9.9 mg/dl, and her PTH level fell to 4.57 pg/ml. A Straus et al first described lipohyperplasia as a 50% fat/50% parenchymal pattern of normal mature parathyroid tissue and glands that were on average fivetimes the weight of normal parathyroid glands.' The difference between lipohyperplasia and other types of parathyroid hyperplasia isthat the increase in sizeisdue to lipomatous tissue and not other stromal components. Histologically, glands affected by lipohyperplasia are similar in appearance to lipoadenomas and demonstrate an increase in both stromal fat and parenchyma. 4 Despite this histologic similarity, lipohyperplasia differs from lipoadenoma in thatlipohyperplasia is present in all four glands. Parathyroid glands with lipohyperplasia may be confused histologically with hamartomas. However, hamartomas have a complex organoid parenchymal pattern with a mixture of parathyroid cell types."
The clinical presentation of hyperparathyroidism caused by lipohyperplasia is similar when caused by parathyroid hyperplasia. A review of the previous 9 cases of lipohyperplasia shows that clinical symptoms were noted in 67% of the cases; the mean calcium level was 12.46 mg/dl, and the mean PTH level was elevated 86% of the time. The mean age was 52.4 years, with a female predilection of 3.5:1. The most common presenting symptom was fatigue (66%),and otherreported findings were bone/joint pain, nocturia, depression, memory loss, constipation, signs of cardiovascular disease, and nonspecific EeG changes.'
Parathyroid lipohyperplasia may be difficult to identify by sestamibi scan because there is multi-gland involvement, high adipose content, and relatively small size compared to parathyroid adenomas. Seethala et al performed sestamibi scanning for confirmed cases of lipohyperplasia. In this series of 3 patients, only one had incomplete washout, suggesting four-gland hyperplasia.' Similarly, our patient had a sestamibi scan that did not suggest four-gland hyperplasia; only a subtle mismatch near the right inferior pole of the thyroid was observed. Historically, ultrasonography has been shown to increase the sensitivity of sestamibi to approximately 90% for identifying parathyroid hyperplasia,' but it was not helpful in suggesting abnormal glands in this case.
Histology, PTH levels, and a radioguided gamma probe may serve as helpful intraoperative adjuncts to locate pathologic parathyroid glands. Lipohyperplasia can be diagnosed by frozen section, but this may prove difficult because parathyroid specimens may be seen as normal parathyroid tissue or only adipose tissue. This method isenhanced by measuringand weighing resected specimens to identify large and most likely pathologic specimens.
Monitoring intraoperative PTH for appropriate decline (>50%) after excision is crucial for confirmation that the pathologic tissue has been removed.' In cases in which there is a localizing sestamibi or ultrasound scan and PTH falls by 50% after unilateral exploration and removal of a parathyroid gland, surgery may be concluded.'
In the last decade, intraoperative radioguided resection has been popularized. One larger study examining radioguided gland resection in 92 patients with parathyroid hyperplasia reported a 100% success rate in localizing the hyperfunctional parathyroid glands,"
In the case of parathyroid lipohyperplasia, when there are nonlocalizing preoperative studies, a thorough fourgland exploration should allow the surgeon encountering this rare entity to treat it appropriately. It is presently unknown if intraoperative gamma probing would have been a significant help with the present case, but it is often helpful with nonlocalizing multi-gland disease.
No cases of gross recurrence of lipohyperplasia or lipoadenoma have been reported, and there has been only 1 case of recurrent hypercalcemia after subtotal parathyroldectomy." Despite its rarity, with proper surgical excision one can expect a successful outcome in these cases.
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